Cystic fibrosis-related diabetes testing in Crevalcore
Find health labs to test for Cystic fibrosis-related diabetes in Crevalcore and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Farmacia Beata Vergine della Salute
Corso Canalchiaro, 127, 41121 Modena MO, Italia
12.1 km
Hemoglobin Test by Farmacia Pian di Macina
Via Ottavio Garganelli, 13, 40065 Pianoro BO, Italia
25.2 km
Diabetes Test by GmLab sede di Locorotondo (BA)
Viale Giosuè Carducci, 3, 44034 Copparo FE, Italia
35.5 km
Diabetes Test by Gemini Srl - Poliambulatorio a Parma
Piazza Sisto Rosa Badalocchio, 3, 43126 Parma PR, Italia
40.5 km
Diabetes Test by Synlab
Via Sorte, 48, 37047 San Bonifacio VR, Italia
46.9 km
Hemoglobin Test by Synlab
Piazza Dante Alighieri, 63, 50032 Borgo San Lorenzo FI, Italia
54.4 km
Hemoglobin Test by Synlab Euganea Medica
Via Cristoforo Colombo, 13, 35020 Albignasego PD, Italia
55.7 km
Hemoglobin Test by Centro Igea S. Antimo
Viale degli Oleandri, 38, 48123 Ravenna RA, Italia
55.9 km
Hemoglobin Test by Farmacia Etrusca
Via Pistoiese, 174, 59100 Prato PO, Italia
58.2 km
Hemoglobin Test by Farmacia Picconi
Via Provinciale Montalbano, 371, 51034 Serravalle Pistoiese PT, Italia
58.6 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
